Skip to content

Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction

Safety and Efficacy of Endoscopic Full Thickness Biopsy With Over the Scope Clip in Patients With Chronic Intestinal Pseudo-obstruction: A Single-Center, Single-Arm, Open-label, Interventional Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06943417
Acronym
EFTB-CIPO
Enrollment
20
Registered
2025-04-24
Start date
2025-06-01
Completion date
2030-03-31
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Intestinal Pseudo-obstruction

Keywords

Chronic intestinal pseudo-obstruction, Endoscopic full thickness biopsy

Brief summary

To evaluate the safety and efficacy of endoscopic full thickness biopsy for the diagnostic purpose of chronic intestinal pseudo-obstruction.

Interventions

DEVICEOver the scope clip

over the scope clip group

Sponsors

International University of Health and Welfare
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with chronic pseudo intestinal obstruction or suspected chronic pseudo intestinal obstruction * Patients who are 18 years of age or older at the time of obtaining consent * Gender: Any

Exclusion criteria

* Patients for whom it is difficult to perform endoscopy * Patients who cannot obtain consent * Patients with serious renal, hepatic, or cardiac disease * Patients who are participating in other clinical research, except for observational research. * Other patients whom the principal investigator or subinvestigator determines to be inappropriate to conduct this study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of total perforations (intraoperative and delayed perforations)Immediately after the interventionPercentage of total perforations (intraoperative and delayed perforations)

Secondary

MeasureTime frameDescription
Rate of delayed perforationPeriproceduralRate of delayed perforation
Intraoperative complicationsUnder procedureIntraoperative complications
Intraoperative death rateUnder procedureIntraoperative death rate
Examination timeUnder procedureExamination time
Macroscopic specimen sizeImmediately after procedureMacroscopic specimen size
Intraoperative perforation rateUnder procedureIntraoperative perforation rate
Whether tissue evaluation is acceptable for biopsy purposesImmediately after procedureWhether tissue evaluation is acceptable for biopsy purposes
Ratio of postoperative complicationsImmediately after procedureRatio of postoperative complications
Time or days of fluid intake postoperativelyFrom date of procedure until the date of first fluid intake assessed up to 12 monthsTime or days of fluid intake postoperatively
Time or number of days of food intake after procedureFrom date of procedure until the date of first food intake assessed up to 12 monthsTime or number of days of food intake after procedure
Length of hospital stayFrom date of procedure until the date of discharge assessed up to 12 monthsLength of hospital stay
Findings of tissue specimensImmediately after procedureFindings of tissue specimens

Countries

Japan

Contacts

Primary ContactTakaomi Kessoku, M.D., Ph.D.
takaomi0027@gmail.com+81-476-35-5600
Backup ContactYo Ishihara, M.D.
+81-476-35-5600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026